David Degen

991 total citations
13 papers, 504 citations indexed

About

David Degen is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, David Degen has authored 13 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Genetics and 4 papers in Pharmacology. Recurrent topics in David Degen's work include Bacterial Genetics and Biotechnology (7 papers), RNA and protein synthesis mechanisms (6 papers) and Microbial Natural Products and Biosynthesis (4 papers). David Degen is often cited by papers focused on Bacterial Genetics and Biotechnology (7 papers), RNA and protein synthesis mechanisms (6 papers) and Microbial Natural Products and Biosynthesis (4 papers). David Degen collaborates with scholars based in United States, Germany and Italy. David Degen's co-authors include Richard H. Ebright, Yu Zhang, Yon W. Ebright, Yu Feng, Sukhendu Mandal, Eddy Arnold, Nancy Connell, Meliza Talaue, Wei Lin and William Fenical and has published in prestigious journals such as Cell, Nature Communications and Molecular Cell.

In The Last Decade

David Degen

13 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Degen United States	10	333	136	131	111	96	13	504
Matthieu Fonvielle France	19	579 1.7×	105 0.8×	92 0.7×	56 0.5×	121 1.3×	43	778
Ivan A.D. Lessard United Kingdom	14	391 1.2×	156 1.1×	148 1.1×	42 0.4×	115 1.2×	14	791
Ravindranadh V. Somu United States	8	459 1.4×	196 1.4×	115 0.9×	83 0.7×	115 1.2×	8	707
Michael J. Pucci United States	11	271 0.8×	261 1.9×	98 0.7×	50 0.5×	108 1.1×	14	521
Karen O’Dwyer United States	9	274 0.8×	76 0.6×	64 0.5×	97 0.9×	96 1.0×	12	456
Veerasak Srisuknimit United States	11	349 1.0×	63 0.5×	218 1.7×	35 0.3×	59 0.6×	14	529
Andrew Galgoci United States	7	240 0.7×	61 0.4×	81 0.6×	37 0.3×	183 1.9×	8	463
Natalie K. Garcia United States	10	288 0.9×	96 0.7×	65 0.5×	108 1.0×	31 0.3×	12	526
Rakesh K. Dhiman United States	10	343 1.0×	270 2.0×	65 0.5×	207 1.9×	74 0.8×	14	578
Lorenza Favrot United States	7	255 0.8×	126 0.9×	43 0.3×	106 1.0×	42 0.4×	9	408

Countries citing papers authored by David Degen

Since Specialization

Citations

This map shows the geographic impact of David Degen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Degen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Degen more than expected).

Fields of papers citing papers by David Degen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Degen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Degen. The network helps show where David Degen may publish in the future.

Co-authorship network of co-authors of David Degen

This figure shows the co-authorship network connecting the top 25 collaborators of David Degen. A scholar is included among the top collaborators of David Degen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Degen. David Degen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Degen, David, et al.. (2024). Total Synthesis of Marformycins A and D. Organic Letters. 26(46). 10056–10060. 1 indexed citations

Degen, David, et al.. (2023). Stabilizing Pseudouridimycin: Synthesis, RNA Polymerase Inhibitory Activity, and Antibacterial Activity of Dipeptide‐Modified Analogues. ChemMedChem. 19(1). e202300474–e202300474. 2 indexed citations

Makwana, Kamlesh M., et al.. (2022). Total Synthesis of Pargamicin A. Organic Letters. 24(50). 9285–9289. 6 indexed citations

Lin, Wei, Sukhendu Mandal, David Degen, et al.. (2019). Structural basis of ECF-σ-factor-dependent transcription initiation. Nature Communications. 10(1). 710–710. 32 indexed citations

Walker, Scott S., David Degen, Elliott Nickbarg, et al.. (2017). Affinity Selection–Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase Inhibitor. ACS Chemical Biology. 12(5). 1346–1352. 14 indexed citations

Maffioli, Sonia I., Yu Zhang, David Degen, et al.. (2017). Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase. Cell. 169(7). 1240–1248.e23. 107 indexed citations

Lin, Wei, David Degen, Yu Liu, et al.. (2017). Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition. Molecular Cell. 66(2). 169–179.e8. 126 indexed citations

Feng, Yu, David Degen, Xinyue Wang, et al.. (2015). Structural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR Pyrazoles. Structure. 23(8). 1470–1481. 19 indexed citations

Hassan, Hossam M., David Degen, Kyoung Hwa Jang, Richard H. Ebright, & William Fenical. (2014). Salinamide F, new depsipeptide antibiotic and inhibitor of bacterial RNA polymerase from a marine-derived Streptomyces sp.. The Journal of Antibiotics. 68(3). 206–209. 38 indexed citations

10.

Liu, Shuang, et al.. (2014). Synthesis and Evaluation of Novel Analogues of Ripostatins. Chemistry - A European Journal. 20(38). 12310–12319. 16 indexed citations

11.

Zhang, Yu, David Degen, Mary Ho, et al.. (2014). GE23077 binds to the RNA polymerase ‘i’ and ‘i+1’ sites and prevents the binding of initiating nucleotides. eLife. 3. e02450–e02450. 59 indexed citations

12.

Degen, David, Yu Feng, Yu Zhang, et al.. (2014). Transcription inhibition by the depsipeptide antibiotic salinamide A. eLife. 3. e02451–e02451. 62 indexed citations

13.

Srivastava, Aashish, David Degen, Yon W. Ebright, & Richard H. Ebright. (2012). Frequency, Spectrum, and Nonzero Fitness Costs of Resistance to Myxopyronin in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 56(12). 6250–6255. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact